Rene Furtig

Global Head of Neuroscience & Mental Health BD&L at Boehringer Ingelheim International GmbH

Speaker

Dr. René Fuertig is the Global Head of CNS BD+L at Boehringer Ingelheim, based in Germany. In this role, he and his team scout for first-in-class and breakthrough opportunities around the globe to find novel treatment approaches in the field of Neuroscience, specifically in Pain, Neurodegeneration & Mental health disorders.

Dr. René Fuertig is a scientist and drug development expert with over 10 years of R&D experience. Before his current role, he led due diligences of preclinical and clinical stage in-licensing opportunities in the fields of Oncology, Cardio-Renal Metabolism, and CNS. Earlier, Dr. Fuertig held several positions at Boehringer Ingelheim mainly in CNS / Mental Health disorders, leading preclinical and clinical drug development teams and projects. This included roles as Project Leader for clinical and preclinical drug development projects, as well as subject matter expert in Translational Medicine and Clinical Pharmacology. Dr. Fuertig is a pharmacist by training and holds a PhD (University of Ulm, Germany) and an MBA from Goethe Business School in Frankfurt, Germany.

Driven by a commitment to collaborative innovation, Dr. Fuertig aims to foster transformative partnerships that advance the future of neuroscience.